185 related articles for article (PubMed ID: 15254202)
1. Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface.
Novakovic S; Sawai ET; Radke K
J Virol; 2004 Aug; 78(15):8301-11. PubMed ID: 15254202
[TBL] [Abstract][Full Text] [Related]
2. [Studies on bovine leukemia virus envelope glycoprotein gp30 YXXL sequences in virus infection and fusogenic activity].
Inabe K
Hokkaido Igaku Zasshi; 1998 May; 73(3):239-52. PubMed ID: 9719950
[TBL] [Abstract][Full Text] [Related]
3. The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions.
Inabe K; Nishizawa M; Tajima S; Ikuta K; Aida Y
J Virol; 1999 Feb; 73(2):1293-301. PubMed ID: 9882334
[TBL] [Abstract][Full Text] [Related]
4. Three YXXL Sequences of a Bovine Leukemia Virus Transmembrane Protein are Independently Required for Fusion Activity by Controlling Expression on the Cell Membrane.
Matsuura R; Inabe K; Otsuki H; Kurokawa K; Dohmae N; Aida Y
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835517
[TBL] [Abstract][Full Text] [Related]
5. Bovine leukemia virus gp30 transmembrane (TM) protein is not tyrosine phosphorylated: examining potential interactions with host tyrosine-mediated signaling.
Hamilton VT; Stone DM; Pritchard SM; Cantor GH
Virus Res; 2002 Dec; 90(1-2):155-69. PubMed ID: 12457971
[TBL] [Abstract][Full Text] [Related]
6. The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events.
Beaufils P; Choquet D; Mamoun RZ; Malissen B
EMBO J; 1993 Dec; 12(13):5105-12. PubMed ID: 8262054
[TBL] [Abstract][Full Text] [Related]
7. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.
Johnston ER; Albritton LM; Radke K
J Virol; 2002 Nov; 76(21):10861-72. PubMed ID: 12368329
[TBL] [Abstract][Full Text] [Related]
8. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo.
Gatot JS; Callebaut I; Mornon JP; Portetelle D; Burny A; Kerkhofs P; Kettmann R; Willems L
J Biol Chem; 1998 May; 273(21):12870-80. PubMed ID: 9582317
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis of envelope glycoproteins from diverse geographical isolates of bovine leukemia virus identifies highly conserved peptide motifs.
Pluta A; Albritton LM; Rola-Łuszczak M; Kuźmak J
Retrovirology; 2018 Jan; 15(1):2. PubMed ID: 29310678
[TBL] [Abstract][Full Text] [Related]
10. The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads.
Willems L; Gatot JS; Mammerickx M; Portetelle D; Burny A; Kerkhofs P; Kettmann R
J Virol; 1995 Jul; 69(7):4137-41. PubMed ID: 7769672
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis of tyrosine and di-leucine motifs in the HIV-1 envelope cytoplasmic domain results in a loss of Env-mediated fusion and infectivity.
Bhakta SJ; Shang L; Prince JL; Claiborne DT; Hunter E
Retrovirology; 2011 May; 8():37. PubMed ID: 21569545
[TBL] [Abstract][Full Text] [Related]
12. Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.
Lamb D; Schüttelkopf AW; van Aalten DM; Brighty DW
Retrovirology; 2008 Aug; 5():70. PubMed ID: 18680566
[TBL] [Abstract][Full Text] [Related]
13. Exosomal sorting of the cytoplasmic domain of bovine leukemia virus TM Env protein.
De Gassart A; Trentin B; Martin M; Hocquellet A; Bette-Bobillo P; Mamoun R; Vidal M
Cell Biol Int; 2009 Jan; 33(1):36-48. PubMed ID: 18992834
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide.
Yang C; Compans RW
J Virol; 1996 Jan; 70(1):248-54. PubMed ID: 8523533
[TBL] [Abstract][Full Text] [Related]
15. Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.
Gatot JS; Callebaut I; Van Lint C; Demonté D; Kerkhofs P; Portetelle D; Burny A; Willems L; Kettmann R
J Virol; 2002 Aug; 76(16):7956-67. PubMed ID: 12134000
[TBL] [Abstract][Full Text] [Related]
16. Role of the proline-rich motif of bovine leukemia virus transmembrane protein gp30 in viral load and pathogenicity in sheep.
Reichert M; Winnicka A; Willems L; Kettmann R; Cantor GH
J Virol; 2001 Sep; 75(17):8082-9. PubMed ID: 11483753
[TBL] [Abstract][Full Text] [Related]
17. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.
Berlioz-Torrent C; Shacklett BL; Erdtmann L; Delamarre L; Bouchaert I; Sonigo P; Dokhelar MC; Benarous R
J Virol; 1999 Feb; 73(2):1350-61. PubMed ID: 9882340
[TBL] [Abstract][Full Text] [Related]
18. Cell surface expression of the bovine leukemia virus-binding receptor on B and T lymphocytes is induced by receptor engagement.
Lavanya M; Kinet S; Montel-Hagen A; Mongellaz C; Battini JL; Sitbon M; Taylor N
J Immunol; 2008 Jul; 181(2):891-8. PubMed ID: 18606640
[TBL] [Abstract][Full Text] [Related]
19. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
20. A dileucine motif and a cluster of acidic amino acids in the second cytoplasmic domain of the batten disease-related CLN3 protein are required for efficient lysosomal targeting.
Storch S; Pohl S; Braulke T
J Biol Chem; 2004 Dec; 279(51):53625-34. PubMed ID: 15469932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
